Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosis

There is evidence that intake of proton pump inhibitors (PPI) increases the risk for spontaneous bacterial peritonitis (SBP) in patients with liver cirrhosis. However, data regarding the impact of PPI intake on occurrence of infections other than SBP are still lacking. We hypothesized that PPI use i...

Descripción completa

Detalles Bibliográficos
Autores principales: Labenz, Christian, Kostev, Karel, Galle, Peter R., Wörns, Marcus-Alexander, Labenz, Joachim, Tanislav, Christian, Adarkwah, Charles Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738005/
https://www.ncbi.nlm.nih.gov/pubmed/33327272
http://dx.doi.org/10.1097/MD.0000000000023436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738005/
https://www.ncbi.nlm.nih.gov/pubmed/33327272
http://dx.doi.org/10.1097/MD.0000000000023436

Ejemplares similares